Acorns Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$808K Buy
3,052
+68
+2% +$17.9K 0.01% 57
2026
Q2
$758K Buy
2,984
+299
+11% +$69.7K ﹤0.01% 59
2026
Q1
$656K Buy
2,685
+246
+10% +$57.3K ﹤0.01% 57
2025
Q4
$505K Buy
2,439
+200
+9% +$39.6K ﹤0.01% 64
2025
Q3
$415K Buy
2,239
+212
+10% +$36.3K ﹤0.01% 64
2025
Q2
$310K Buy
2,027
+441
+28% +$67.8K ﹤0.01% 65
2025
Q1
$263K Buy
+1,586
New +$248K ﹤0.01% 66

Other funds holding JNJ

Acorns Advisers's JNJ Position: Q3 2026 in Review

Acorns Advisers increased its Johnson & Johnson (JNJ) stake by 2.3% in Q3 2026, buying an estimated $17.9K and bringing the position to 3,052 shares worth $808K. The position accounts for 0.01% of the portfolio, ranked #57.

Acorns Advisers first reported a position in JNJ in Q1 2025 and has held it in 7 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Acorns Advisers held 3,052 shares of Johnson & Johnson worth $808K as of Q3 2026.
  • Acorns Advisers bought 68 Johnson & Johnson shares in Q3 2026, an estimated $17.9K.
  • Johnson & Johnson made up 0.01% of Acorns Advisers's portfolio in Q3 2026, its #57 holding.
  • Acorns Advisers first reported a position in Johnson & Johnson in Q1 2025 and has held it in 7 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Acorns Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.